Last reviewed · How we verify

NCT07044414

Effectiveness of Manual Acupuncture for Head and Neck Cancer Patients Undergoing Chemoradiation

Completed NA Last updated 31 December 2025
What this trial tests

NA trial testing Manual Acupuncture in Head and Neck Neoplasms in 34 participants. Completed in 12 December 2025.

Timeline
1 September 2025
Primary endpoint
12 December 2025
12 December 2025

Quick facts

Lead sponsorIndonesia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingdouble
Primary purposetreatment
Enrollment34
Start date1 September 2025
Primary completion12 December 2025
Estimated completion12 December 2025
Sites1 location across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Indonesia University

Who can join

18 and older, any sex, with Head and Neck Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to assess whether manual acupuncture (MA) is more effective than sham acupuncture in improving leukocyte count and reducing cancer-related fatigue (CRF) in head and neck cancer (HNC) patients undergoing chemoradiation therapy (CRT). The main questions it aims to answer are: * Does MA, compared to sham acupuncture, increase leukocyte and absolute neutrophil count (ANC) during CRT? * Does MA, compared to sham acupuncture, reduce the severity of CRF as measured by the Visual Analogue Scale-Fatigue (VAS-F)? * Does MA, compared to sham acupuncture, improve quality of life as measured by the EORTC QLQ-C30 questionnaire? Participants will: * Be adult patients with head and neck cancer who have completed induction chemotherapy and are undergoing CRT * Be screened based on inclusion and exclusion criteria, including normal INR and platelet count above 25,000/mm³ * Be randomly assigned to either the MA group or sham group using Park sham needle * Receive acupuncture at points ST36, SP6, CV4, and CV6 three times per week for seven sessions (total 21 sessions) * Be evaluated for leukocyte count, ANC, fatigue (VAS-F), and quality of life (EORTC QLQ-C30) at baseline and at weekly intervals during therapy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Manual Acupuncture

Trials testing the same drug.

Other recruiting trials for Head and Neck Neoplasms

Currently open trials in the same condition.

Other Indonesia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07044414.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing